Prognostic factors for progression-free survival (PFS), overall survival (OS), and long-term OS (LT-OS) with sunitinib in 1,059 patients, treated on clinical trials, with metastatic renal cell carcinoma (mRCC) Meeting Abstract


Authors: Motzer, R. J.; Escudier, B.; Bukowski, R.; Rini, B. I.; Hutson, T. E.; Barrios, C. H.; Lin, X.; Fly, K.; Matczak, E.; Gore, M. E.
Abstract Title: Prognostic factors for progression-free survival (PFS), overall survival (OS), and long-term OS (LT-OS) with sunitinib in 1,059 patients, treated on clinical trials, with metastatic renal cell carcinoma (mRCC)
Meeting Title: 16th ECCO - 36th ESMO - 30th ESTRO European Multidisciplinary Cancer Congress (EMCC 2011)
Journal Title: European Journal of Cancer
Volume: 47
Issue: Suppl. 1
Meeting Dates: 2011 Sep 23-27
Meeting Location: Stockholm, Sweden
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2011-09-01
Start Page: S98
End Page: S99
Language: English
ACCESSION: WOS:000295752800343
PROVIDER: wos
DOI: 10.1016/S0959-8049(11)70649-9
Notes: --- - Meeting Abstract: 1006 - European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care - SEP 23-27, 2011 - Stockholm, SWEDEN - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer